EDBI

Established in 1991, EDBI is a global investor based in Singapore. It focuses on select high-growth sectors such as Information and Communication Technology (ICT), Emerging Technology (ET), Healthcare (HC), and strategic industries. As a value-adding investor, EDBI supports companies by providing network resources, expertise, and patient capital to facilitate growth in Asia and globally.

Harold Au

Principal

Paul Ng

CEO

Jolene Ooi

Senior Principal

Heng Tong Choo

Executive Vice President and Executive Board Member

Andrew Ekaputra Ph.D

Principal

Christine Giam

Partner

180 past transactions

Callio Therapeutics

Series A in 2025
Callio Therapeutics specializes in the development of advanced antibody-drug conjugates (ADCs) for cancer treatment. Their focus is on creating multi-payload ADCs, which allow for the targeted delivery of drug combinations to tumor cells, potentially maximizing therapeutic benefits and improving patient outcomes.

Island

Series D in 2024
Island is a cybersecurity company that specializes in enterprise browser solutions. It offers a web browser tailored for businesses, enabling secure and efficient work environments. Island's platform provides organizations with comprehensive control, visibility, and governance over their online activities, enhancing performance and minimizing cybersecurity risks. The company fosters a collaborative work culture, valuing integrity, quality, and honesty in its interactions with clients.

Zinc Money

Seed Round in 2024
Zinc Money provides fast and secure international money transfers, specializing in helping students and individuals send money from India. With the convenience of UPI integration, users can now transfer funds abroad effortlessly. Zinc Money offers quick and affordable money transfer solutions for education, travel, and everyday expenses with transparent fees and strong security. Whether you need to send money internationally or manage global transactions, Zinc simplifies the process, making it an ideal choice for users transferring money from India.

Sunbird Bio

Venture Round in 2024
Sunbird Bio is a diagnostics platform developer focused on advancing molecular diagnostics to deliver faster and more accurate results. Founded by Huilin Shao, the company specializes in detecting a wide array of diseases, including infectious diseases, neurodegenerative disorders, and cancer. By enabling early diagnosis, Sunbird Bio aims to enhance healthcare outcomes and support physicians in making informed decisions. The platform is designed to improve clarity and accessibility in diagnostic testing, thereby contributing to better patient care.

Arta Finance

Venture Round in 2024
Arta Finance builds a digital family office and fintech software designed to democratize wealth management by providing access, personalization, and a comprehensive set of services at lower costs than traditional family offices. Founded in 2021 by former Google executives, Arta aims to empower a broader audience to grow, protect, and enjoy their wealth by using artificial intelligence and machine learning to simplify consumer financing strategies and enable easier participation in financial markets.

Riverlane

Series C in 2024
Riverlane is a developer of quantum computing software focused on transforming experimental technology into commercial products. The company engineers innovative instruments in collaboration with quantum computer manufacturers, addressing the need for new hardware and software tools to manage the instability of qubits and rectify system defects at unprecedented speeds. Riverlane's software includes an ultra-low latency quantum operating system that accelerates quantum-classical hybrid algorithms, supporting hardware research and development. Additionally, the company creates algorithms designed to optimize the use of the entire quantum computing stack, assisting hardware partners in minimizing the system errors that currently challenge quantum computing capabilities.

ShareChat

Debt Financing in 2024
ShareChat is an Indian social media startup founded in 2015 and headquartered in Bangalore, Karnataka. It provides a content consumption and sharing platform specifically designed for the diverse vernacular audience in India, supporting 15 Indian languages. The platform caters to over 1.17 billion wireless network users in the country, allowing them to share videos, jokes, songs, and other social content. ShareChat includes features for private messaging and tagging, making it easy for users to connect and communicate in their preferred language.

Leo Cancer Care

Series C in 2024
Leo Cancer Care develops an integrated cancer treatment system designed to simplify radiation therapy and improve patient experience. Founded in Australia, the company promotes upright patient positioning and a shift from machine rotation to patient rotation, supported by global research on its clinical benefits. The system combines three-dimensional imaging with automated control of radiation beams to deliver the appropriate energy to the targeted tissue, enabling radiotherapy centers to reduce pain, time, and cost. It can be integrated with standard radiotherapy equipment to support image-guided delivery and streamlined workflows. By prioritizing patient positioning and precise dose delivery, Leo Cancer Care aims to improve treatment accuracy, accessibility, and safety in cancer care.

Artera

Venture Round in 2024
Artera develops medical artificial intelligence tests that personalize therapy for cancer patients. Its tests predict therapeutic benefits and prognosticate patient outcomes. The Artera platform is purely software, and runs on digital images of H&E histopathology images as part of routine clinical care.

LXA

Seed Round in 2023
LXA is a fintech venture focused on reimagining Asia's mortgage ecosystem. Geared towards matching institutional capital pools and residential mortgage borrowers, this platform aims to utilize end-to-end technology to streamline the entire mortgage lifecycle, from loan origination and borrower processing to loan servicing. LXA was founded in early 2023 by seasoned executives across the asset management, insurance, mortgage, and technology industries to bridge the gap between mortgage assets and institutional capital in Asia, beginning with Singapore. Combining best practices from North American and European markets with a proprietary technology platform focused on digital credit decisioning and intelligent workflow orchestration, LXA provides the first of its kind solution to address strong demand from Asian insurers and borrowers for differentiated mortgage products.

Engine Biosciences

Series A in 2023
Engine Biosciences, established in 2014 and headquartered in Singapore, specializes in drug discovery and cellular reprogramming. The company's core offering is a validated platform that combines artificial intelligence and genetic perturbation to uncover gene interactions and biological networks. This platform enables researchers and drug developers to create targeted therapies and apply precision medicine. Engine Biosciences caters to prominent American corporations and research institutions, accelerating and reducing the costs of R&D for new medical therapies.

Automera

Series A in 2023
Automera specializes in innovative drug development methods, focusing on autophagy modulation. It employs advanced computational chemistry, AI, and quantum molecular dynamics to design chimeric small molecules targeting both autophagy and specific disease pathways.

Endowus

Series C in 2023
Endowus is a digital wealth management platform that facilitates comprehensive investment strategies. It offers conflict-free fees, transparent pricing, cashback on trailer fees, and ensures security in investment decisions.

Mirxes

Series D in 2023
MiRXES Pte. Ltd., founded in 2014 and based in Singapore, specializes in life science research tools and molecular diagnostic tests for both research and clinical applications. The company has developed a leading microRNA (miRNA) detection assay platform designed to identify cancer at asymptomatic stages. Its product offerings include RT-qPCR assays, assay panels, spike-in RNA kits, and solutions for biomarker discovery. By focusing on early cancer detection, MiRXES provides healthcare professionals with essential diagnostic tools to improve clinical outcomes through timely intervention.

Engine Biosciences

Series A in 2023
Engine Biosciences, established in 2014 and headquartered in Singapore, specializes in drug discovery and cellular reprogramming. The company's core offering is a validated platform that combines artificial intelligence and genetic perturbation to uncover gene interactions and biological networks. This platform enables researchers and drug developers to create targeted therapies and apply precision medicine. Engine Biosciences caters to prominent American corporations and research institutions, accelerating and reducing the costs of R&D for new medical therapies.

Moloco

Secondary Market in 2023
Moloco Inc., founded in 2013 and based in Palo Alto, California, specializes in programmatic advertising solutions aimed at optimizing client acquisition, retention, and monetization strategies. The company offers a cloud-based demand-side platform that leverages machine learning to help businesses of all sizes enhance user acquisition and maximize lifetime value through predictive models. Additionally, Moloco provides a mobile e-commerce platform that supports targeted re-engagement campaigns, allowing application publishers and e-commerce platforms to expand their customer reach more effectively than traditional advertising methods. With a team comprised of top talents from leading tech firms, Moloco is committed to empowering mobile businesses to thrive in a competitive landscape.

EdgeQ

Series B in 2023
EdgeQ Inc., established in 2018 with headquarters in Santa Clara, California, develops and manufactures open and programmable 5G system-on-a-chip (SoC). The company specializes in converged connectivity and AI, offering fully software-customizable solutions. EdgeQ serves a diverse range of industries including manufacturing, construction, energy, automotive, warehousing, surveillance, and telecommunications. Its products enable collaborative robotics, automated guided vehicles, autonomous driving, traffic management, digital twins, and private networking for innovative applications across various sectors.

Thunes

Series C in 2023
Thunes is a global B2B payment infrastructure platform established in 2016, specializing in cross-border payment solutions. It facilitates seamless fund transfers between various payment systems, catering to a diverse range of clients, including major players in the gig economy and fintech sectors. The platform enables businesses and consumers to send and receive payments in 80 currencies across 132 countries, supporting 300 payment methods. Thunes offers a suite of services including remittance processing, mass payouts, virtual accounts, and payment collection, utilizing application programming interfaces (APIs) to enhance accessibility and reduce transaction costs. In April 2022, the company expanded its capabilities by acquiring a controlling stake in Tookitaki, a compliance platform that strengthens its anti-money laundering and fraud prevention measures. Headquartered in Singapore, Thunes operates regional offices in key global cities such as London, Paris, and Dubai, positioning itself as a vital player in the international payment landscape.

Proxtera

Seed Round in 2023
Proxtera is a platform facilitating cross-border trade, particularly for small and medium-sized enterprises. It employs artificial intelligence to uncover pricing opportunities, access supply chains, and leverage digital technologies.

Lionsbot

Series A in 2023
Lionsbot is a Singapore-based robotics company specializing in developing cleaning robots for commercial, industrial, and public spaces. The company's founders leverage their expertise in cleaning and robotics to create highly versatile robots, with all software and hardware developed in-house. Lionsbot aims to transform everyday living by providing smart cleaning solutions that clients love.

Doctor Anywhere

Series C in 2022
Doctor Anywhere is a Singapore-based telehealth company that provides on-demand healthcare solutions. Its digital platform offers quick access to health and wellness services, optimized for convenient lifestyle management.

Resolve BioSciences

Series B in 2022
Resolve BioSciences GmbH, founded in 2016 and based in Monheim am Rhein, Germany, specializes in spatial multiomics analysis platforms that enhance the understanding of single-cell spatial biology. The company's innovative technology enables researchers to obtain high-resolution spatial views of subcellular gene expression activities. Resolve BioSciences offers a range of services that encompass bioinformatics, imaging, genomics, transcriptomics, histology, and pathology, among others. Their expertise extends to various fields, including neuroscience, oncology, infectious diseases, and agrigenomics, facilitating advanced studies in cell atlasing and single-cell analysis.

Structo

Venture Round in 2022
Structo is a digital manufacturing platform specializing in dental 3D printing services. The company has developed a range of application-specific 3D printing resins that complement its proprietary hardware technology. By focusing on enhancing the speed and efficiency of 3D printing, Structo enables users to achieve higher throughput at lower costs compared to traditional stereolithography (SLA) printers. Their innovative approach allows dental professionals to revolutionize their business models while maintaining high print quality.

ImmunoScape

Venture Round in 2022
ImmunoScape develops immune profiling systems and analytical tools to support immunotherapy clinical development. Its Deep Immunomics platform integrates mass cytometry, single-cell sequencing, and proprietary computational analytics to profile immune cells with high resolution and to identify antigen-specific T cells, delivering an online data analysis pipeline. The platform provides reproducible immune profiling information used to understand safety and efficacy of immunotherapies and to identify drug targets across oncology and infectious diseases, applicable throughout research, development, and clinical testing.

Fazz

Series C in 2022
Founded in 2016, Fazz is a Singapore and Indonesia-based company that empowers merchants from small businesses to large corporations across Southeast Asia. It offers Fazz Agen, serving micro and small enterprises, and Fazz Business, providing payment solutions, capital growth opportunities, and funding access.

Pico

Private Equity Round in 2022
Pico is a prominent provider of technology services tailored for the financial markets sector. The company offers a comprehensive network platform that enables clients to access financial markets instantly. This platform is enhanced with advanced analytics and telemetry capabilities, ensuring transparency and low-latency solutions. Pico's innovative approach allows clients to operate efficiently and gain a competitive advantage in the rapidly evolving financial landscape. Its agile service delivery model further supports the needs of clients seeking to navigate the complexities of financial trading effectively.

Wefox

Series D in 2022
Wefox is a technology company specializing in the insurance sector. It operates a digital platform that connects insurance providers, brokers, businesses, and customers, facilitating access to various insurance solutions. The company focuses on indirect sales, partnering with intermediaries to expand its market reach. Wefox's platform offers services such as policy management, claims settlement, and quotation generation for a range of insurance types, including health, liability, and disability.

DataStax

Private Equity Round in 2022
DataStax is a technology company that develops database software for cloud applications. It offers enterprise-scale data platforms built on Apache Cassandra, including DataStax Enterprise and Astra, a database-as-a-service for Cassandra applications designed to accelerate deployment and scale. The company also provides management and development tools such as OpsCenter for monitoring, DevCenter for querying, and K8ssandra, a Kubernetes distribution of Cassandra, along with Constellation, a cloud data platform, and it offers training, support, and consulting. DataStax serves large enterprises, government agencies, and systems integrators. In addition, DataStax provides tools for building AI-powered applications, including a vector database with real-time data processing and integration capabilities, APIs and data pipelines to deploy AI apps, semantic search functionality, and compatibility with machine learning frameworks. The company was founded in 2010 and is based in Santa Clara, California, with additional offices worldwide.

Tessa Therapeutics

Series A in 2022
Tessa Therapeutics specializes in developing immunotherapies for solid tumors. Its platform focuses on redirecting the body's antiviral immune response to recognize and kill cancer cells, offering new treatment options for patients.

Neuron Mobility

Series B in 2022
Neuron Mobility is a rental e-scooter and e-bike company focused on providing safe and convenient transportation solutions for urban commuting. The company operates a fleet of distinctive orange e-scooters, which are designed and manufactured in-house to meet commercial standards, ensuring enhanced performance and durability compared to standard models. Utilizing high-accuracy location technology and rapid geofence detection, Neuron Mobility effectively monitors and corrects unsafe riding behavior, promoting a safer riding experience. The company's platform integrates real-time telematics to cater to various segments, including personal mobility, goods delivery, and tourism, thereby facilitating affordable and comfortable short-distance travel for city residents.

RVAC Medicines

Series B in 2022
Founded in Singapore in 2021, RVAC Medicines is a biotechnology company specializing in the development of novel mRNA vaccines and therapeutics. It focuses on addressing unmet medical needs, particularly in emerging markets, through its cutting-edge GMP manufacturing facilities and platform technologies.

Biofourmis

Series D in 2022
Biofourmis is a biotechnology company based in Boston, Massachusetts, founded in 2015. It specializes in personalized care and therapies through the use of digital therapeutics. The company develops and delivers clinically validated software-based therapeutics that enhance patient outcomes. Biofourmis has created a predictive health analytics platform that analyzes physiology data gathered from clinical-grade wearables. Utilizing artificial intelligence, this platform integrates and interprets continuous physiological data to identify personalized patterns and predict potential clinical exacerbations. By enabling medical professionals to intervene days before critical events occur, Biofourmis aims to improve patient care and provide cost-effective solutions for healthcare providers.

Us2.ai

Series A in 2022
Us2.ai specializes in developing artificial intelligence-driven software and digital tools for echocardiography. Based in Singapore, it offers online solutions to simplify access to echo analysis results and heart ultrasound.

Maya

Convertible Note in 2022
Maya is a Philippines-based technology company and a wholly-owned subsidiary of Smart Communications, Inc., operating under the umbrella of First Pacific. The company specializes in providing innovative digital solutions aimed at developing new business streams and adapting to evolving business models. Maya offers a comprehensive range of services, including merchant acquiring, domestic and international remittance, payment acceptance, mobile payments, card issuing, and digital financial services. Additionally, the company focuses on digital payments, e-wallets, digital lending, and digital banking, positioning itself as a key player in the financial technology sector and addressing the growing demand for modern, efficient financial solutions.

Beam

Series B in 2022
Beam Mobility Holdings Pte. Ltd. is a micro-mobility company that offers electric scooters for rent through a user-friendly mobile application. Established in 2018 and based in Singapore, Beam aims to enhance urban mobility by providing a network of shared e-scooters that can be easily accessed on a pay-per-use basis. The company promotes responsible parking by incentivizing users to return scooters to designated parking spots, thereby minimizing clutter on city streets. By leveraging Internet of Things technology, Beam contributes to improved last-mile connectivity, helps alleviate traffic congestion, and supports environmental sustainability efforts.

Mirxes

Series C in 2022
MiRXES Pte. Ltd., founded in 2014 and based in Singapore, specializes in life science research tools and molecular diagnostic tests for both research and clinical applications. The company has developed a leading microRNA (miRNA) detection assay platform designed to identify cancer at asymptomatic stages. Its product offerings include RT-qPCR assays, assay panels, spike-in RNA kits, and solutions for biomarker discovery. By focusing on early cancer detection, MiRXES provides healthcare professionals with essential diagnostic tools to improve clinical outcomes through timely intervention.

Modalku

Series C in 2022
Modalku is an online marketplace based in Jakarta, Indonesia, designed to connect small businesses seeking loans with lenders looking to fund these loans. By leveraging technology, Modalku offers borrowers access to financing options that may not be available through traditional channels, often at lower interest rates. Lenders participating in the platform can achieve returns that surpass those typically found in bank deposits and traditional investment products. This marketplace lending model has been successfully implemented in various countries, including the USA, UK, China, and Singapore, demonstrating its effectiveness in supporting small business growth.

Funding Societies

Series C in 2022
Funding Societies, established in 2015 and headquartered in Singapore, operates a digital financing platform that connects small and medium-sized enterprises (SMEs) with investors. The company facilitates business loans, focusing on quick and efficient financing solutions, often bypassing traditional banking methods. It offers a range of flexible financing options, including micro and term loans, and invoice financing, using advanced credit scoring and risk assessment models. With operations across Southeast Asia, including Singapore, Malaysia, Indonesia, and Thailand, Funding Societies caters to SMEs seeking accessible and timely financing.

Next Gen Foods

Series A in 2022
Next Gen Foods is a food-tech startup that offers plant-based meat products. Its plant-based products look and taste like meat and are developed using agricultural food ecosystems helping consumers to have foods that are rich in protein and nutrients. The company was founded in 2020 and is headquartered in Singapore.

Hazel Technologies

Venture Round in 2022
Hazel Technologies develops and produces postharvest technologies that extend the shelf life of fresh produce. The company’s core product is a carton insert that releases ethylene inhibitors, such as 1‑MCP, to slow respiration and aging in fruits and vegetables, thereby reducing spoilage and waste. In addition to its hardware, Hazel offers horticultural consulting and supply‑chain solutions that help growers, shippers, and retailers optimize storage conditions and inventory management. Founded in 2015, the company is headquartered in Chicago, Illinois, with an additional site in Salinas, California. Its technologies have been validated by academic research and supported by USDA funding, positioning Hazel as a key player in improving the efficiency and sustainability of the fresh‑produce supply chain.

Sleek

Series A in 2021
Sleek is a platform that provides company registration, compliance, and financial services for small and medium enterprises. It offers a digital solution that handles incorporation, accounting, tax, payroll, and other administrative tasks to streamline business management and automate routine processes, helping entrepreneurs focus on growth. The services cover incorporation, government filings, taxes, visas, and regulatory compliance, enabling clients to manage compliance online and maintain governance with ease.

Bolttech

Series A in 2021
Bolttech is an international InsurTech company that develops an AI-based point-of-sale insurance platform. This platform offers a range of insurance products, including device protection, travel, motor, property, life, and digital insurance to consumers. Bolttech aims to create a technology-enabled ecosystem for protection and insurance, with a notable presence in Asia.

Ember

Series E in 2021
Ember is a design-led brand specializing in temperature control technology, founded by inventor Clay Alexander. The company aims to transform the way individuals consume food and beverages through its innovative products. Ember's flagship offerings include the Ember Travel Mug and Ember Mug, both recognized for their advanced temperature control capabilities, allowing users to set and maintain their preferred drinking temperatures for hot beverages. These products enhance the flavor experience of drinks like coffee and tea by enabling personalized temperature settings. Ember's smart mugs are sold in prominent retail outlets, including Best Buy, Apple, Williams Sonoma, Costco, and Target. In addition to its core drinkware line, Ember is expanding its temperature control technology into new sectors such as healthcare and infant feeding, demonstrating its commitment to innovation and customization in everyday living.

Endowus

Venture Round in 2021
Endowus is a digital wealth management platform that facilitates comprehensive investment strategies. It offers conflict-free fees, transparent pricing, cashback on trailer fees, and ensures security in investment decisions.

ShopBack

Series E in 2021
ShopBack is a leading online shopping platform in Southeast Asia that focuses on enhancing consumer purchasing decisions through cashback and rewards. Operating in several countries including Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, the company facilitates over 1,000 orders per hour by offering up to 30% cashback on purchases made through its platform. With a portfolio of over 1,300 merchant partners such as Uber, Expedia, and Lazada, ShopBack provides consumers with curated deals while simultaneously delivering effective marketing solutions for its business partners. The company is recognized for its impact in the industry, having received multiple awards, including accolades for Best Start-up and Best Innovative Infocomm Products at the Singapore Infocomm Technology Federation Awards, as well as the Emerging Enterprise Award, highlighting its role in enriching the shopping experience for consumers.

Advance Intelligence Group

Series D in 2021
Advance Intelligence Group is a financial technology firm that builds an ecosystem of AI-powered, credit-enabled products, and services. Founded in 2016, it leverages innovative technology and partnerships to build an ecosystem of products and services serving consumers, enterprises, and merchants.

Neuroglee Health

Series A in 2021
Neuroglee Health is a digital therapeutic platform focused on addressing the needs of patients in the early stages of neurodegenerative diseases. The company develops innovative therapeutic devices that offer treatment and monitoring tools aimed at preserving cognitive function and promoting patient independence. By utilizing cognitive and neurobehavioral mechanisms, Neuroglee Health engages users on an individual basis, enabling them to take an active role in their treatment. The platform also provides consistent insights into the efficacy of therapies, which can facilitate accelerated drug development. Through its comprehensive approach, Neuroglee Health aims to empower patients and improve their quality of life while navigating the challenges posed by neurodegenerative conditions.

Nature's Fynd

Series C in 2021
Nature's Fynd is a food company that specializes in producing protein from extremophile organisms discovered in geothermal springs. Founded in 2012 and headquartered in Chicago, Illinois, with an additional office in Bozeman, Montana, the company employs innovative fermentation technology to cultivate its protein. This method significantly reduces the land and water resources typically required for traditional agriculture. Nature's Fynd aims to create foods that not only nourish people but also promote environmental sustainability.

Mirxes

Series C in 2021
MiRXES Pte. Ltd., founded in 2014 and based in Singapore, specializes in life science research tools and molecular diagnostic tests for both research and clinical applications. The company has developed a leading microRNA (miRNA) detection assay platform designed to identify cancer at asymptomatic stages. Its product offerings include RT-qPCR assays, assay panels, spike-in RNA kits, and solutions for biomarker discovery. By focusing on early cancer detection, MiRXES provides healthcare professionals with essential diagnostic tools to improve clinical outcomes through timely intervention.

AvePoint

Post in 2021
AvePoint, Inc. is a leading provider of software solutions and services designed for users of SharePoint and Office 365, focusing on data migration, management, and protection. Founded in 2001 and headquartered in Jersey City, New Jersey, the company serves over 21,000 customers globally, ensuring data security and compliance across various cloud environments, including Microsoft, Google, and Salesforce. AvePoint offers a range of products, including compliance solutions that address privacy and information security risks, as well as tools for data protection, operational governance, and records management. Its Confidence Platform provides cloud-based solutions for IT operations, development operations, and cybersecurity, facilitating secure collaboration and digital transformation. The company's extensive partner program includes over 3,500 managed service providers and systems integrators, making its solutions available in more than 100 cloud marketplaces.

SCI Ecommerce

Venture Round in 2021
SCI Ecommerce is a digital commerce software provider that specializes in marketing services designed to enhance brand awareness and conversion rates for its clients. The company focuses on creating data-driven, user-specific marketing campaigns that facilitate connections with target audiences and drive sales across various platforms. SCI Ecommerce supports businesses by offering comprehensive solutions, including the development of online storefronts and the production of high-quality content aligned with clients' objectives and brand image. Additionally, the company assists clients in navigating complex supply chains, ultimately enabling them to achieve robust growth and increased profitability.

Nuevocor

Series A in 2021
Nuevocor is a preclinical-stage biopharmaceutical company dedicated to developing gene therapy-based treatments aimed at restoring cardiac function in hearts affected by disease. The company specializes in addressing genetic cardiomyopathies, which are characterized by abnormal mechanobiology. By focusing on modulating mechanical force transduction, Nuevocor seeks to provide innovative solutions that enable healthcare professionals to improve cardiac function in patients suffering from these conditions.

Engine Biosciences

Series A in 2021
Engine Biosciences, established in 2014 and headquartered in Singapore, specializes in drug discovery and cellular reprogramming. The company's core offering is a validated platform that combines artificial intelligence and genetic perturbation to uncover gene interactions and biological networks. This platform enables researchers and drug developers to create targeted therapies and apply precision medicine. Engine Biosciences caters to prominent American corporations and research institutions, accelerating and reducing the costs of R&D for new medical therapies.

Esco Lifesciences

Series A in 2021
Esco Lifesciences Group supplies advanced technologies, products, and services tailored for life sciences and healthcare sectors. It facilitates academic research, clinical practice, and biopharmaceutical development and manufacturing.

Hummingbird Bioscience

Series C in 2021
Hummingbird Bioscience employs systems biology to uncover disease mechanisms and uses computational platforms for discovering and engineering innovative biotherapeutics. Its pipeline includes HMBD-001 (anti-HER3 antibody) and HMBD-002 (anti-VISTA antibody), both in cancer treatment. The company collaborates strategically with Cancer Research UK and Amgen.

VNLIFE

Venture Round in 2021
VNLIFE is a technology company that develops a digital ecosystem for the tourism, logistics, and commerce sectors. It offers a range of digital products, including payment and service platforms, to individual consumers. The company aims to empower startups by providing technical expertise, business guidance, network building, and capital, enabling them to grow domestically and compete globally.

NEON

Private Equity Round in 2021
NEON is a global leader specializing in creating and producing immersive experiences. It partners with renowned brands like Disney, Marvel, NBCUniversal, and Warner Bros., as well as governments for original artifact exhibitions. NEON has brought compelling experiences to millions of visitors across over 60 cities worldwide.

ImmunoScape

Venture Round in 2021
ImmunoScape develops immune profiling systems and analytical tools to support immunotherapy clinical development. Its Deep Immunomics platform integrates mass cytometry, single-cell sequencing, and proprietary computational analytics to profile immune cells with high resolution and to identify antigen-specific T cells, delivering an online data analysis pipeline. The platform provides reproducible immune profiling information used to understand safety and efficacy of immunotherapies and to identify drug targets across oncology and infectious diseases, applicable throughout research, development, and clinical testing.

vArmour Networks

Venture Round in 2021
vArmour Networks provides software-defined security solutions for virtualized data centers worldwide. It offers SDSec, a network-based security enforcement layer for cloud computing environments, and a multi-cloud security architecture. The company separates the security control plane from the enforcement plane to enhance security in hybrid cloud infrastructure.

Pico

Series C in 2020
Pico is a prominent provider of technology services tailored for the financial markets sector. The company offers a comprehensive network platform that enables clients to access financial markets instantly. This platform is enhanced with advanced analytics and telemetry capabilities, ensuring transparency and low-latency solutions. Pico's innovative approach allows clients to operate efficiently and gain a competitive advantage in the rapidly evolving financial landscape. Its agile service delivery model further supports the needs of clients seeking to navigate the complexities of financial trading effectively.

Pear Therapeutics

Series D in 2020
Pear Therapeutics, Inc. is a Boston-based commercial-stage healthcare company specializing in software-based digital therapeutics, also known as Prescription Digital Therapeutics (PDTs). Founded in 2013, the company develops clinically validated software solutions designed to treat a range of behavioral health disorders, including addiction, anxiety, depression, and chronic insomnia. Its suite of products includes mobile digital therapies that reward patients for engagement, and specific tools like reSET and reSET-O, aimed at treating substance use disorders. The company also offers Somryst, which provides neurobehavioral interventions for insomnia, and operates PearConnect, a patient services center that connects patients with advocates and resources, ensuring support throughout their treatment journey. Pear Therapeutics aims to enhance treatment outcomes by integrating digital therapies with pharmaceuticals and providing comprehensive support for patients, clinicians, and payors.

Gaiaworks

Series D in 2020
GaiaWorks is a developer of a cloud-based workforce management platform designed to enhance operational efficiency for organizations. The company’s solution integrates various functionalities, including time and attendance tracking, intelligent scheduling, and labor optimization, to simplify compliance and control labor costs. By utilizing data prediction based on the analysis of historical business metrics, such as sales volume and transaction numbers, GaiaWorks enables businesses to forecast labor needs effectively, typically on a weekly basis. This approach helps organizations improve labor efficiency, mitigate compliance risks, and enhance employee satisfaction.

Seismic

Series F in 2020
Seismic is a global leader in enablement, providing a unified platform that empowers customer-facing teams with skills, content, tools, and insights to drive revenue growth. Serving over 2,000 organizations worldwide, Seismic automates sales material creation, improves close rates, and enhances marketing impact.

Biofourmis

Series C in 2020
Biofourmis is a biotechnology company based in Boston, Massachusetts, founded in 2015. It specializes in personalized care and therapies through the use of digital therapeutics. The company develops and delivers clinically validated software-based therapeutics that enhance patient outcomes. Biofourmis has created a predictive health analytics platform that analyzes physiology data gathered from clinical-grade wearables. Utilizing artificial intelligence, this platform integrates and interprets continuous physiological data to identify personalized patterns and predict potential clinical exacerbations. By enabling medical professionals to intervene days before critical events occur, Biofourmis aims to improve patient care and provide cost-effective solutions for healthcare providers.

Livspace

Series D in 2020
Founded in 2014 by Anuj Srivastava and Ramakant Sharma, Livspace is an interior design startup that offers a comprehensive platform connecting users with designers, services, and products. It specializes in end-to-end home interior services, including kitchen upgrades and room renovations.

Aetion

Series B in 2020
Aetion is a New York‑based company that builds a real‑world evidence platform. It aggregates claims, electronic health records, registries and clinical trial data to generate analytics that help payers, providers, biopharma and medical device firms assess the effectiveness and value of treatments. The platform’s rapid‑cycle analytics enable real‑time collaboration between payers, providers and life‑science companies, supporting value‑based care decisions. Founded in 2012 by Harvard Medical School faculty and data scientists, it has partnerships with McKesson and receives backing from major venture investors. The platform is used worldwide by health‑economists, epidemiologists and biostatisticians for database analytics and comparative‑effectiveness research.

Rigetti Computing

Series C in 2020
Rigetti Computing is a full-stack quantum computing company that designs, manufactures, and deploys quantum integrated circuits in low-temperature environments. It develops control systems for quantum logic operations and software to integrate its systems into existing cloud infrastructure. The company focuses on near-term applications in computational chemistry and machine learning, offering the world's first full-stack programming and execution environment for quantum/classical computing.

Vesta

Venture Round in 2020
Vesta Corporation is a provider of electronic payment solutions, specializing in client-branded services that enhance payment processing for merchants. The company offers a range of merchant solutions, including vSafe for Small to Midsize Businesses, which focuses on payment and fraud protection for smaller digital goods merchants, and vSafe for Enterprise, designed for comprehensive payments management and enterprise-level fraud prevention. Additionally, Vesta provides vGuaranteed, a payment solution tailored for online retailers, and DelayPay, a retail installment program that allows prepaid wireless customers to pay for services in installments. Founded in 1995 and headquartered in Lake Oswego, Oregon, Vesta operates globally, with centers in the United States, Ireland, China, and an office in Singapore. The company serves diverse industries, including e-commerce, telecommunications, and financial services, processing hundreds of millions of secure payments across various channels while prioritizing data security and fraud loss elimination.

Transcelestial Technologies

Series A in 2020
Founded in Singapore in 2016, Transcelestial develops high-speed wireless communication networks using laser technology. Its space data network aims to transmit data up to 1000x faster than current methods for terrestrial and satellite applications.

Erasca

Series B in 2020
Erasca is a clinical-stage precision oncology company dedicated to discovering and developing therapies for patients with cancers driven by the RAS/MAPK pathway. Founded in 2018, the company's pipeline includes Naporafenib, ERAS-007, and ERAS-601, targeting various nodes of this pathway.

Screening Eagle Technologies

Series A in 2020
Founded in 2019, Screening Eagle Technologies develops a cloud-based platform that connects sensors, software, and data for intelligent inspection of assets and infrastructure. The company offers solutions such as project management workflows, post-processing analysis, and industrial surface testing.

Doctor Anywhere

Series B in 2020
Doctor Anywhere is a Singapore-based telehealth company that provides on-demand healthcare solutions. Its digital platform offers quick access to health and wellness services, optimized for convenient lifestyle management.

ElevateBio

Series B in 2020
Founded in 2017, ElevateBio operates a portfolio of companies focused on developing, manufacturing, and commercializing transformative cell and gene therapies for severe diseases. Through strategic partnerships with leading scientists and inventors, along with a centralized facility for efficient translation of R&D into viable therapies, the company aims to deliver life-changing medicines to patients.

ShopBack

Series B in 2020
ShopBack is a leading online shopping platform in Southeast Asia that focuses on enhancing consumer purchasing decisions through cashback and rewards. Operating in several countries including Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, the company facilitates over 1,000 orders per hour by offering up to 30% cashback on purchases made through its platform. With a portfolio of over 1,300 merchant partners such as Uber, Expedia, and Lazada, ShopBack provides consumers with curated deals while simultaneously delivering effective marketing solutions for its business partners. The company is recognized for its impact in the industry, having received multiple awards, including accolades for Best Start-up and Best Innovative Infocomm Products at the Singapore Infocomm Technology Federation Awards, as well as the Emerging Enterprise Award, highlighting its role in enriching the shopping experience for consumers.

Eko Health

Venture Round in 2020
Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

eko.ai

Funding Round in 2020
Eko.ai Pte. Ltd. is a Singapore-based company that specializes in developing artificial intelligence software for the early detection and treatment of heart disease. Founded in 2017, the company focuses on democratizing echocardiography and ultrasound technology to identify cardiovascular risks more effectively. Eko.ai collaborates with clinician scientists, sonographers, and deep learning experts to create automated tools that enhance the capabilities of research teams in the field of cardiac imaging. Its software provides fully classified, machine learning-ready research databases, along with a suite of models, segmentation tools, and validation cohorts. By equipping hospital systems with these productivity tools, Eko.ai aims to improve health outcomes for patient populations while advancing the fight against heart disease.

SWAT Mobility

Series A in 2019
SWAT Mobility is a developer of advanced vehicle-routing technology that addresses intricate transportation challenges faced by companies, transport operators, and government agencies globally. Utilizing an artificial intelligence algorithm, the company specializes in optimizing route planning for large-scale transportation by enabling vehicle pooling and dynamic route adjustments. This innovative approach has been shown to significantly reduce transportation costs, enhance connectivity within cities, and alleviate traffic congestion. SWAT Mobility has established itself as a leader in the industry, demonstrating superior performance through its smart mobility optimization engine, which positions it well for future advancements in autonomous vehicle technology.

M-DAQ

Venture Round in 2019
M-DAQ is a pioneering platform that enables pricing and trading of exchange-traded products in multiple currencies. It blends executable foreign exchange rates into equities and futures products, facilitating cross-border transactions without significant system changes.

NEON

Private Equity Round in 2019
NEON is a global leader specializing in creating and producing immersive experiences. It partners with renowned brands like Disney, Marvel, NBCUniversal, and Warner Bros., as well as governments for original artifact exhibitions. NEON has brought compelling experiences to millions of visitors across over 60 cities worldwide.

Nuvation Bio

Series A in 2019
Nuvation Bio is a global biopharmaceutical company dedicated to developing innovative therapies for oncology, focusing on patients with difficult-to-treat cancers where conventional treatments have proven ineffective.

Structo

Series D in 2019
Structo is a digital manufacturing platform specializing in dental 3D printing services. The company has developed a range of application-specific 3D printing resins that complement its proprietary hardware technology. By focusing on enhancing the speed and efficiency of 3D printing, Structo enables users to achieve higher throughput at lower costs compared to traditional stereolithography (SLA) printers. Their innovative approach allows dental professionals to revolutionize their business models while maintaining high print quality.

DataRobot

Series E in 2019
DataRobot develops an automated machine learning platform that enables users across various industries to build predictive models. Its cloud-based solution, DataRobot Cloud, offers a project-based curriculum for gaining insights from data scientists. The company also provides DataRobot MLOps for deploying and managing machine learning models, along with enterprise features like flexible deployment and governance in its DataRobot Enterprise solution.

Inari

Series C in 2019
Inari is a biotechnology company focused on revolutionizing agriculture and its societal and environmental impact. The company utilizes advanced technologies, including predictive design and multiplex gene editing, to maximize the potential of seeds. Its unique SEEDesign platform distinguishes Inari by enabling the enhancement of various crops across different geographies, facilitating the development of innovative agricultural products. By embracing diversity, Inari fosters innovation and aims to contribute to the creation of a new food system.

Circles.Life

Venture Round in 2019
Circles.Life is a Singapore-based digital telecommunications company offering post-paid mobile and internet data services through subscription-based data plans. It provides a mobile app to monitor usage, manage costs, browse and purchase plans, and switch between plans, with a focus on flexible, no-contract offerings and a strong customer experience.

Biofourmis

Series B in 2019
Biofourmis is a biotechnology company based in Boston, Massachusetts, founded in 2015. It specializes in personalized care and therapies through the use of digital therapeutics. The company develops and delivers clinically validated software-based therapeutics that enhance patient outcomes. Biofourmis has created a predictive health analytics platform that analyzes physiology data gathered from clinical-grade wearables. Utilizing artificial intelligence, this platform integrates and interprets continuous physiological data to identify personalized patterns and predict potential clinical exacerbations. By enabling medical professionals to intervene days before critical events occur, Biofourmis aims to improve patient care and provide cost-effective solutions for healthcare providers.

ShopBack

Series B in 2019
ShopBack is a leading online shopping platform in Southeast Asia that focuses on enhancing consumer purchasing decisions through cashback and rewards. Operating in several countries including Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, the company facilitates over 1,000 orders per hour by offering up to 30% cashback on purchases made through its platform. With a portfolio of over 1,300 merchant partners such as Uber, Expedia, and Lazada, ShopBack provides consumers with curated deals while simultaneously delivering effective marketing solutions for its business partners. The company is recognized for its impact in the industry, having received multiple awards, including accolades for Best Start-up and Best Innovative Infocomm Products at the Singapore Infocomm Technology Federation Awards, as well as the Emerging Enterprise Award, highlighting its role in enriching the shopping experience for consumers.

Carro

Series B in 2019
Carro is an automotive marketplace that offers a full-stack service for all aspects of car ownership. It challenges the traditional way of buying and selling of cars through a proprietary pricing algorithm. Carro also provides a range of services that offer everything a car owner needs throughout their car ownership journeys such as an in-house financing solution warranty options and Singapore’s first on-demand roadside recovery platform. The company was founded in 2015 and is headquartered in Singapore.

Zilingo

Series D in 2019
Zilingo is a technology-driven platform founded in 2015 by Ankiti Bose and Dhruv Kapoor, aimed at transforming the fashion supply chain through innovative trade solutions. By digitizing the fashion industry, Zilingo provides a marketplace that connects brands and merchants directly with factories, offering essential tools such as analytics, efficient logistics, and secure payment options. This approach enables entrepreneurs to thrive in a sector that has historically favored a select few, promoting accessibility, transparency, and connection within the fashion ecosystem. Zilingo's vision is to democratize fashion, making it possible for anyone with the right ideas to succeed in the industry.

Pear Therapeutics

Series C in 2019
Pear Therapeutics, Inc. is a Boston-based commercial-stage healthcare company specializing in software-based digital therapeutics, also known as Prescription Digital Therapeutics (PDTs). Founded in 2013, the company develops clinically validated software solutions designed to treat a range of behavioral health disorders, including addiction, anxiety, depression, and chronic insomnia. Its suite of products includes mobile digital therapies that reward patients for engagement, and specific tools like reSET and reSET-O, aimed at treating substance use disorders. The company also offers Somryst, which provides neurobehavioral interventions for insomnia, and operates PearConnect, a patient services center that connects patients with advocates and resources, ensuring support throughout their treatment journey. Pear Therapeutics aims to enhance treatment outcomes by integrating digital therapies with pharmaceuticals and providing comprehensive support for patients, clinicians, and payors.

Pindrop

Series D in 2018
Pindrop specializes in voice-driven security and intelligence solutions for enterprises. It leverages unique audio analysis technology to authenticate calls, detect fraud, and enhance customer experiences across various industries.

WalkMe

Series F in 2018
WalkMe Inc., founded in 2011 and headquartered in San Francisco, California, develops a cloud-based guidance and engagement platform designed to enhance user experience and productivity. Their Digital Adoption Platform adapts software to meet the needs of employees and customers, while WalkMe Automation simplifies user experiences by automating complex tasks. The company also offers solutions for modernizing legacy desktop applications and enhancing security. WalkMe's platform integrates with various systems, including Salesforce and Workday, and serves sectors such as financial services, healthcare, insurance, retail, software, utility, and education. With additional offices in New York, Raleigh, London, Tel Aviv-Yafo, Sydney, and Tokyo, WalkMe is a subsidiary of WalkMe Ltd.

Ambiq Micro

Series E in 2018
Ambiq Micro, Inc. is a fabless semiconductor company based in Austin, Texas, specializing in the development of ultra-low power integrated circuits tailored for power-sensitive applications. Founded in 2010, the company utilizes innovative subthreshold power optimized technology to create real-time clock and microcontroller products designed for wearables, smart cards, wireless sensors, and Internet-of-Things devices. By focusing on ultra-low-power mixed-signal solutions, Ambiq Micro aims to enhance the efficiency of wireless electronics, facilitating the creation of devices that either minimize or eliminate battery use while maximizing design flexibility. The company also provides technical support services and operates additional offices in San Jose, California, as well as in Shanghai, Shenzhen, and Taiwan.

Moka

Series B in 2018
Moka is a Jakarta-based technology company that specializes in developing a cloud-based point-of-sale application and integrated card reader solutions for small and medium-sized businesses. Founded in 2014, Moka's application enables users to process payments via debit and credit cards while also providing features such as sales reporting across multiple outlets, inventory tracking, customer feedback collection, and analytics. The company offers a range of hardware, including Apple iPads, printers, cash drawers, barcode scanners, and mobile point-of-sale devices, catering to various sectors such as coffee shops, barbershops, retail stores, and restaurants, as well as mobile vendors like food trucks and kiosks. Moka operates on a subscription-based model, charging users a monthly fee that varies according to the number of locations they manage. This approach allows business owners to access real-time sales data stored in the cloud from any location.

OakNorth Bank

Series B in 2018
OakNorth Bank is a UK-based digital-first commercial bank that provides debt financing and related services to growth-oriented businesses. It targets the Missing Middle, established SMEs underserved by traditional banks, offering bespoke secured and unsecured loans, property funding, and related financial solutions, alongside savings products for individuals and businesses. Founded in 2015 and headquartered in London, the bank uses data-led analytics and forward-looking scenario analysis to assess risk and support scalable growth through cycles. Its client base includes property developers, care homes, schools, hotels, and other growth ventures, with lending supported by long-term partnerships rather than equity. The bank emphasizes a relationship-driven approach, with a sizable share of new lending generated through referrals and repeat borrowers.

I-Mab Biopharma

Series C in 2018
I-Mab Biopharma (Shanghai) Co., Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China, with additional offices in Beijing and Rockville, Maryland. Founded in 2016, the company focuses on the discovery, development, and commercialization of innovative biologics aimed at addressing significant unmet medical needs, particularly in the fields of immuno-oncology and immuno-inflammation. I-Mab's diverse drug pipeline targets various therapeutic areas, including multiple myeloma, autoimmune diseases, pediatric growth hormone deficiency, and several cancer indications such as head and neck cancer. Key candidates in its portfolio include Uliledlimab, an antibody for solid tumors, along with Ragistomig and Givastomig, highlighting the company's commitment to developing transformative therapies for patients.

Puppet

Series F in 2018
Puppet is an information technology company that specializes in automation solutions aimed at addressing common business challenges. The company offers a comprehensive platform for infrastructure automation, covering areas such as configuration management, compliance, application delivery, and patch management. Puppet's tools facilitate the development, management, version control, and code analysis necessary for effective IT operations. By enabling clients to deliver, update, monitor, and secure software across both physical and virtual machines, Puppet enhances operational efficiency and reliability in IT environments.

BITMAIN

Series B in 2018
Bitmain is a leading manufacturer of Bitcoin mining hardware, specializing in the development and sale of miners utilizing ASIC chip technology. Founded by pioneers in the digital currency sector, the company is staffed by a team of skilled engineers, financial experts, and cryptocurrency enthusiasts. Headquartered in Beijing, Bitmain also maintains offices in cities such as San Francisco, Tel Aviv, Hong Kong, Chengdu, and Shenzhen. The company focuses on providing high-quality, efficient computing solutions, including high-density server equipment and large-scale parallel computing software, to support the cryptocurrency mining industry.

Carousell

Series C in 2018
Carousell is a Singapore-based classifieds marketplace that enables peer-to-peer buying and selling of preloved items through a mobile app available on iOS and Android. The platform supports categories such as fashion, gadgets, home and living, and cars, allowing users to create free listings by snapping a photo and posting a description. Launched in August 2012 in Singapore, Carousell has expanded to about 19 cities across seven countries, pursuing a simple, community-driven selling experience. The service has been recognized as a leading shopping app in several regions and has attracted investment from notable venture-capital firms to fuel its growth.

Rotimatic

Series C in 2018
Zimplistic, founded in 2008 by Rishi Israni and Pranoti Nagarkar, is a kitchen robotics startup focused on improving healthy eating through innovative technology. Its flagship product, Rotimatic, is the world's first fully automatic roti-making appliance that uses artificial intelligence to create fresh, homemade flatbreads with minimal human intervention. Launched in 2016, Rotimatic processes essential ingredients and produces hot, delicious rotis in under a minute, offering a user-friendly solution for busy households. The appliance has gained significant popularity, serving over 3 million rotis in thousands of homes by mid-2017. Available in several countries including Singapore, the US, the UK, Canada, Australia, and New Zealand, Rotimatic aims to simplify meal preparation and promote healthier eating habits by enabling users to enjoy homemade food made from carefully selected ingredients.

H3 Dynamics

Series B in 2018
H3 Dynamics develops hydrogen-based propulsion and energy solutions for aerospace and defense, including hydrogen-electric fuel cell systems for airport operations and aircraft, with applications from extending the range of small electric UAS to powering MW-scale passenger aircraft, and on-site hydrogen production and refueling for airports and remote drone operators. The company also designs telerobotics drones and cloud-based analytics that convert imagery, video, LiDAR, and other sensor data into expert-validated inspection reports for asset owners, operators, contractors, and financial services firms, enabling real-time response and actionable insights. With more than 16 years of research and development experience, H3 Dynamics maintains a global footprint across multiple regions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.